Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

17.70
Delayed Data
As of Sep 28
 +0.08 / +0.45%
Today’s Change
15.22
Today|||52-Week Range
31.32
-33.71%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close17.62
Today’s open17.75
Day’s range17.25 - 17.80
Volume313,833
Average volume (3 months)630,407
Market cap$688.1M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-50.59%
Earnings growth (next 5 years)+70.57%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.39

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...-0.05-0.52%
AIMTAimmune Therapeutics...-0.10-0.65%
ZIOPZIOPHARM Oncology In...+0.43+7.85%
CORTCorcept Therapeutics...-0.05-0.76%
Data as of 09/28/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Search for Jobs